RPRX - Royalty Pharma plc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$53.75
DETAILS
HIGH:
$63.00
LOW:
$45.00
MEDIAN:
$53.50
CONSENSUS:
$53.75
DOWNSIDE:
1.38%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Revenue | 2,378.2 | 2,263.6 | 2,354.6 | 2,237.2 | 2,289.5 | 2,122.4 | 1,814.3 | 1,794.9 | 1,597.9 | 1,877.4 | 1,652.4 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 2,378.2 | 2,263.6 | 2,354.6 | 2,237.2 | 2,289.5 | 2,122.4 | 1,814.3 | 1,794.9 | 1,597.9 | 1,877.4 | 1,652.4 |
| Operating Expenses | |||||||||||
| R&D Expenses | 452 | 2 | 52 | 177.1 | 200.1 | 26.3 | 83.0 | 392.6 | 117.9 | 91.0 | 98.4 |
| SG&A Expenses | 573.5 | 236.7 | 249.7 | 227.3 | 182.8 | 181.7 | 103.4 | 61.9 | 106.4 | 69.5 | 121.4 |
| Other Expenses | (206.8) | 732.5 | 560.7 | 1,525.7 | 475.8 | 318.9 | (995.4) | (24.1) | 433.9 | 925.8 | 570.2 |
| Operating Expenses | 818.7 | 971.1 | 862.4 | 1,930.2 | 858.7 | 527.0 | (808.9) | 430.4 | 658.2 | 1,086.3 | 790.0 |
| Operating Income | |||||||||||
| Operating Income | 1,559.5 | 1,292.4 | 1,492.2 | 307.1 | 1,430.7 | 1,595.4 | 2,623.2 | 1,364.4 | 939.7 | 722.9 | 794.3 |
| Interest Expense | 307.7 | 225.5 | 187.2 | 188.0 | 166.1 | 157.1 | 268.6 | 280.0 | 247.3 | 238.9 | 224.4 |
| Interest Income | 33.6 | 47.3 | 72.3 | 78.3 | 53.5 | 28.4 | 22.3 | 24.4 | 6.8 | 0 | 0 |
| Profitability | |||||||||||
| EBITDA | 1,635.7 | 1,556.3 | 1,887.3 | 423.7 | 1,430.3 | 1,882.1 | 2,753.9 | 1,831.1 | 1,623.8 | 1,069.0 | 862.4 |
| EBIT | 1,631.9 | 1,556.3 | 1,887.3 | 418.0 | 1,407.3 | 1,859.0 | 2,730.0 | 1,797.8 | 1,590.5 | 1,000.8 | 983.1 |
| Income Before Tax | 1,324.2 | 1,330.8 | 1,700.1 | 230.1 | 1,241.2 | 1,702.0 | 2,461.4 | 1,517.9 | 1,343.2 | 761.9 | 758.7 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 770.9 | 859.0 | 1,134.8 | 42.8 | 619.7 | 975.0 | 2,348.5 | 1,377.7 | 1,210.0 | 565.9 | 581.4 |
| Per Share Data | |||||||||||
| EPS (Basic) | 2.33 | 1.92 | 3.41 | 0.10 | 1.49 | 1.28 | 6.63 | 3.89 | 3.42 | 0.93 | 0.96 |
| EPS (Diluted) | 1.80 | 1.91 | 2.53 | 0.10 | 1.49 | 1.28 | 6.63 | 3.89 | 3.42 | 0.93 | 0.96 |
| Shares Outstanding | 431.9 | 446.0 | 447.6 | 438.0 | 414.8 | 388.1 | 354.2 | 354.2 | 354.2 | 607.0 | 607.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 618.7 | 929.0 | 477.0 | 1,710.8 | 1,541.0 | 1,008.7 | 246.2 | 1,924.2 | 1,381.6 | 1,674.2 |
| Short-Term Investments | 18.8 | 842.0 | 756.7 | 717.0 | 1,262.2 | 1,640.5 | 547.0 | 461.8 | 0 | 0 |
| Net Receivables | 883.7 | 27.0 | 22.4 | 36.6 | 68.3 | 39.2 | 38.8 | 198.6 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | (902.2) | 4.2 | 18.0 | 90.5 | 6.6 | 8.6 | 0.1 | 23.9 | 1,566.1 | 1,329.9 |
| Total Current Assets | 619 | 1,802.1 | 1,274.2 | 2,554.9 | 2,878.2 | 2,696.9 | 832.1 | 2,608.6 | 2,947.7 | 3,004.1 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 924.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 15,127.2 | 0 | 0 | 5.7 | 28.7 | 51.7 | 75.6 | 0 | 0 |
| Long-Term Investments | 171.3 | 16,387.0 | 15,101.1 | 14,228.9 | 14,627.8 | 13,284.7 | 11,478.1 | 8,666.8 | 0 | 0 |
| Other Non-Current Assets | 15,967.1 | (15,093.6) | 6.5 | 29.6 | 4.1 | 10.0 | 88.0 | 19.1 | 0 | 0 |
| Total Non-Current Assets | 17,063 | 16,420.6 | 15,107.7 | 14,258.6 | 14,637.7 | 13,323.4 | 11,617.8 | 8,761.6 | 8,425.8 | 7,477.9 |
| Total Assets | 19,620.8 | 18,222.7 | 16,381.9 | 16,813.5 | 17,515.9 | 16,020.3 | 12,449.9 | 11,370.1 | 11,373.5 | 10,482.0 |
| Current Liabilities | ||||||||||
| Account Payables | 19.4 | 13.4 | 15.2 | 7.9 | 5.6 | 10.8 | 11.2 | 4.5 | 0 | 0 |
| Short-Term Debt | 380 | 997.8 | 0 | 997.5 | 0 | 0 | 282.0 | 281.4 | 280.9 | 172.7 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 164.0 | 68.6 | 11.4 | 12.4 | 0 | 18.6 | 9.2 | 0 | 102.5 | 124.6 |
| Total Current Liabilities | 636.2 | 1,253.6 | 161.4 | 1,166.8 | 171.2 | 307.9 | 333.4 | 580.2 | 383.4 | 297.3 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 8,570.9 | 6,614.7 | 6,135.3 | 6,118.8 | 7,096.1 | 5,816.6 | 5,956.1 | 6,237.9 | 6,520.9 | 5,724.7 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 682.6 | 12.1 | 0.9 | 2.5 | 0 | 0 | 18.9 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 9,269.6 | 6,626.7 | 6,136.2 | 6,121.3 | 7,096.1 | 5,816.6 | 5,975.0 | 6,237.9 | 6,520.9 | 5,724.7 |
| Total Liabilities | 9,905.8 | 7,880.3 | 6,297.6 | 7,288.1 | 7,267.3 | 6,124.5 | 6,308.5 | 6,818.1 | 6,904.3 | 6,022.0 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 3,282.5 | 3,282.5 | 0 | 0 |
| Retained Earnings | 2,356.3 | 2,845.7 | 2,517.6 | 1,964.7 | 2,255.2 | 1,920.6 | 2,825.2 | 1,216.0 | 0 | 0 |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 16.5 | 34.4 | 2.1 | (10.3) | 0 | 0 |
| Total Stockholders' Equity | 6,476.9 | 6,946.6 | 6,526.5 | 5,628.1 | 5,776.6 | 4,818.8 | 6,105.6 | 4,488.2 | 4,460.5 | 4,445.6 |
| Total Liabilities & Equity | 19,620.8 | 18,222.7 | 16,381.9 | 16,813.5 | 17,515.9 | 16,020.3 | 12,449.9 | 11,370.1 | 11,364.8 | 10,467.6 |
| Debt Metrics | ||||||||||
| Total Debt | 8,950.9 | 7,612.4 | 6,135.3 | 7,116.3 | 7,096.1 | 5,816.6 | 6,238.1 | 6,519.3 | 6,801.8 | 5,897.4 |
| Net Debt | 8,332.2 | 6,683.4 | 5,658.3 | 5,405.6 | 5,555.0 | 4,807.9 | 5,991.9 | 4,595.1 | 5,420.2 | 4,223.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | 1,324.2 | 1,330.8 | 1,700.1 | 230.1 | 1,241.2 | 1,702.0 | 2,461.4 | 1,517.9 | 1,343.2 |
| Depreciation & Amortization | 3.9 | 0 | 0 | 5.7 | 23.0 | 23.1 | 23.9 | 33.3 | 33.3 |
| Stock-Based Compensation | 289.9 | 2.3 | 2.4 | 2.2 | 2.4 | 5.4 | 0 | 0 | 0 |
| Change in Working Capital | (17.2) | 53.4 | 5.4 | 32.7 | (16.3) | 76.0 | (24.7) | (1,562.4) | (1,475.6) |
| Other Non-Cash Items | 889.0 | 1,382.4 | 1,280.0 | 1,873.4 | 767.2 | 228.2 | (793.4) | 1,629.6 | 1,517.5 |
| Operating Cash Flow | 2,489.8 | 2,769.0 | 2,987.8 | 2,144.0 | 2,017.5 | 2,034.6 | 1,667.2 | 1,618.3 | 1,418.3 |
| Investing Activities | |||||||||
| Capital Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | (74.4) | (11.0) | (12.5) | (9.9) | (34.9) | (40.2) | (27.0) | (24.2) | (2) |
| Purchases of Investments | (1,931.2) | (2,736.2) | (2,115.5) | (2,565.1) | (3,593.7) | (3,937.5) | (2,751.7) | (422.4) | (2,300.7) |
| Sales/Maturities of Investments | 566.5 | 118.4 | 25.8 | 1,545.5 | 1,776.3 | 1,203.3 | 875.1 | 750 | 600 |
| Other Investing Activities | (175.1) | (49.3) | 29.4 | 0 | (18.1) | 15.1 | (250) | 0 | 115 |
| Investing Cash Flow | (1,614.2) | (2,678.1) | (2,072.8) | (1,029.4) | (1,870.3) | (2,759.3) | (2,153.6) | 303.4 | (1,587.7) |
| Financing Activities | |||||||||
| Net Debt Issuance | 954.5 | 1,471.2 | (1,000) | 0 | 1,272.5 | 680.6 | (294) | (294) | 907 |
| Stock Repurchased | (1,227.4) | (229.7) | (304.8) | 0 | 0 | 0 | (4.3) | 0 | 0 |
| Dividends Paid | (378.3) | (376.5) | (358.3) | (333.3) | (285.2) | (397.8) | (739.3) | (814.4) | (735.2) |
| Other Financing Activities | (534.8) | (504.0) | (485.7) | (611.5) | (602.2) | (704.4) | (154.1) | (270.7) | (295.1) |
| Financing Cash Flow | (1,186.0) | 361.1 | (2,148.8) | (944.9) | 385.1 | 1,487.2 | (1,191.6) | (1,379.1) | (123.3) |
| Cash Position | |||||||||
| Net Change in Cash | (310.3) | 452.0 | (1,233.7) | 169.7 | 532.4 | 762.5 | (1,678.0) | 542.6 | (292.6) |
| Cash at Beginning | 929.0 | 477.0 | 1,710.8 | 1,541.0 | 1,008.7 | 246.2 | 1,924.2 | 1,381.6 | 1,674.2 |
| Cash at End | 618.7 | 929.0 | 477.0 | 1,710.8 | 1,541.0 | 1,008.7 | 246.2 | 1,924.2 | 1,381.6 |
| Free Cash Flow | 2,489.8 | 2,769.0 | 2,987.8 | 2,144.0 | 2,017.5 | 2,034.6 | 1,667.2 | 1,618.3 | 1,418.3 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2,378.2 | 2,263.6 | 2,354.6 | 2,237.2 | 2,289.5 | 2,122.4 | 1,814.3 | 1,794.9 | 1,597.9 | 1,877.4 | 1,652.4 |
| Gross Profit | 2,378.2 | 2,263.6 | 2,354.6 | 2,237.2 | 2,289.5 | 2,122.4 | 1,814.3 | 1,794.9 | 1,597.9 | 1,877.4 | 1,652.4 |
| Operating Income | 1,559.5 | 1,292.4 | 1,492.2 | 307.1 | 1,430.7 | 1,595.4 | 2,623.2 | 1,364.4 | 939.7 | 722.9 | 794.3 |
| Net Income | 770.9 | 859.0 | 1,134.8 | 42.8 | 619.7 | 975.0 | 2,348.5 | 1,377.7 | 1,210.0 | 565.9 | 581.4 |
| EPS (Diluted) | 1.80 | 1.91 | 2.53 | 0.10 | 1.49 | 1.28 | 6.63 | 3.89 | 3.42 | 0.93 | 0.96 |
| Balance Sheet | |||||||||||
| Cash & Equivalents | 618.7 | 929.0 | 477.0 | 1,710.8 | 1,541.0 | 1,008.7 | 246.2 | 1,924.2 | 1,381.6 | 1,674.2 | |
| Total Assets | 19,620.8 | 18,222.7 | 16,381.9 | 16,813.5 | 17,515.9 | 16,020.3 | 12,449.9 | 11,370.1 | 11,373.5 | 10,482.0 | |
| Total Debt | 8,950.9 | 7,612.4 | 6,135.3 | 7,116.3 | 7,096.1 | 5,816.6 | 6,238.1 | 6,519.3 | 6,801.8 | 5,897.4 | |
| Stockholders' Equity | 6,476.9 | 6,946.6 | 6,526.5 | 5,628.1 | 5,776.6 | 4,818.8 | 6,105.6 | 4,488.2 | 4,460.5 | 4,445.6 | |
| Cash Flow | |||||||||||
| Operating Cash Flow | 2,489.8 | 2,769.0 | 2,987.8 | 2,144.0 | 2,017.5 | 2,034.6 | 1,667.2 | 1,618.3 | 1,418.3 | ||
| Capital Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Free Cash Flow | 2,489.8 | 2,769.0 | 2,987.8 | 2,144.0 | 2,017.5 | 2,034.6 | 1,667.2 | 1,618.3 | 1,418.3 | ||